Knave, a Paris-based company, has successfully secured €225M in funding from Pollen Street Capital. This funding will enable them to enhance their solutions for offering rental and subscription services to major retailers, addressing the logistics behind consumer goods distribution. Knave's innovative approach supports manufacturers and stores in navigating challenges in the retail landscape, creating a seamless interface across devices that supports the growing trend of subscription models.
Purespring has announced it has raised €95M to advance its mission of developing gene therapies for IgAN, a chronic kidney disease targeting mainly young adults. The funding, resulting from an oversubscribed Series B round, will facilitate Phase I/II clinical trials. This investment comes as a significant boost for Purespring, augmenting its commitment to halting kidney disease's progression by working on therapies that target specialized cells, critical in renal function.
Basecamp Research, with its recent €54M funding from high-profile investors, is set to innovate biological system design using advanced AI technologies. Their approach involves leveraging an extensive biological database to aid biopharma collaborations, marrying computational technology with biological sciences. This funding allows Basecamp to push the boundaries of biological research further, making strides towards understanding and engineering complex biological systems that could transform medical science.
Collection
[
|
...
]